Filter Results:
(505)
Show Results For
- All HBS Web
(505)
- News (62)
- Research (405)
- Events (1)
- Multimedia (8)
- Faculty Publications (375)
Show Results For
- All HBS Web
(505)
- News (62)
- Research (405)
- Events (1)
- Multimedia (8)
- Faculty Publications (375)
- August 2012 (Revised August 2012)
- Case
HealthAllies (A)
By: Regina E. Herzlinger and Michael Sherman
This case describes a "do good and do well" firm that enables individuals to buy health care services at discounted prices. It delineates the characteristics of the uninsured and others who are the primary targets for the firm. "HealthAllies (B)" provides information... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Marketing Channels; Demand and Consumers; Commercialization; Health Industry
Herzlinger, Regina E., and Michael Sherman. "HealthAllies (A)." Harvard Business School Case 302-019, August 2012. (Revised from original August 2001 version.)
- June 15, 2021
- Article
Cutting the Gordian Knot of Employee Health Care Benefits and Costs: A Corporate Model Built on Employee Choice
By: Regina E. Herzlinger and Barak D. Richman
President Joe Biden’s promise to give every American access to affordable health insurance is well-intentioned, but his plan’s policy elements—a public option, a permanent expanded tax credit—require congressional approval and would expend significant political and... View Details
Keywords: Health Insurance; Health Insurance Marketplaces; Health Care Delivery; Health Care Financing; Health Care Industry; Health Care and Treatment; Insurance; Service Delivery; Cost Management; Health Industry; United States
Herzlinger, Regina E., and Barak D. Richman. "Cutting the Gordian Knot of Employee Health Care Benefits and Costs: A Corporate Model Built on Employee Choice." Health Affairs Blog (June 15, 2021).
- August 2012 (Revised August 2024)
- Case
ABC Pharmaceuticals
By: Regina E. Herzlinger and Erik R. Sparks
This case asks students to price a new drug that is in Stage II of its clinical trials. It contains detailed estimates of the time required and costs for all the steps needed to commercialize a drug in the U.S. Students will learn virtually all the steps required to... View Details
Keywords: Drug Development; Price; Product; Product Launch; Health Industry; Technology Industry; Pharmaceutical Industry
Herzlinger, Regina E., and Erik R. Sparks. "ABC Pharmaceuticals." Harvard Business School Case 313-041, August 2012. (Revised August 2024.)
- December 10, 2024
- Other Article
A New Model for Funding Healthcare Innovation
By: Regina E. Herzlinger and Duke Rohlen
Herzlinger, Regina E., and Duke Rohlen. "A New Model for Funding Healthcare Innovation." Harvard Business Review (December 10, 2024).
- March 2021
- Supplement
Humana (C) — Reorganization
By: Regina E. Herzlinger and Ashley Ifeadike
A summary of Humana's restructuring of its business around its pillars. View Details
Keywords: Health Care; Health Care Industry; Health Insurance; Health Care Operations; Health; Health Care and Treatment; Insurance; Operations; Restructuring; Health Industry
Herzlinger, Regina E., and Ashley Ifeadike. "Humana (C) — Reorganization." Harvard Business School Supplement 321-122, March 2021.
- March 2015 (Revised November 2017)
- Case
Bonitas
By: Regina E. Herzlinger and Natalie Kindred
Bonitas, a South African medical scheme (i.e., health insurer), must navigate highly restrictive regulations that make it difficult for Bonitas to innovate, grow, and compete with market leader Discovery as well as providers of alternative insurance products. Bonitas... View Details
Keywords: Health Insurance; Health Care; South Africa; Medical Scheme; Public Policy; Bonitas; Bonitas Medical Fund; National Health Insurance; Health; Health Care and Treatment; Insurance; Policy; Health Industry; Insurance Industry; South Africa; Johannesburg; Africa
Herzlinger, Regina E., and Natalie Kindred. "Bonitas." Harvard Business School Case 315-020, March 2015. (Revised November 2017.)
- August 2014 (Revised February 2021)
- Case
Hospital for Special Surgery (A)
By: Regina E. Herzlinger and Stacy Schwartz
Hospital for Special Surgery, a focused factory for orthopedics and joint disease, is contemplating various growth options: further growth in the United Kingdom's National Health Services, management of hospitals in the United States, and/or hospital consulting.... View Details
Keywords: Health Care and Treatment; Nonprofit Organizations; Growth and Development Strategy; Cross-Cultural and Cross-Border Issues; Expansion; Health Industry; United Kingdom; United States
Herzlinger, Regina E., and Stacy Schwartz. "Hospital for Special Surgery (A)." Harvard Business School Case 315-012, August 2014. (Revised February 2021.)
- August 2014
- Case
Blue Cross Blue Shield of Florida, Inc.
By: Regina E. Herzlinger and Meng Li
Keywords: Health; Health Care Industry; Health Insurance; United States; Health Care and Treatment; Health Industry; United States; Florida
Herzlinger, Regina E., and Meng Li. "Blue Cross Blue Shield of Florida, Inc." Harvard Business School Case 315-009, August 2014.
- April 1995 (Revised August 1995)
- Supplement
Empire Blue Cross and Blue Shield (C)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Supplements the (A) case. View Details
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (C)." Harvard Business School Supplement 195-218, April 1995. (Revised August 1995.)
- September 2013 (Revised August 2014)
- Case
Ping An Health (PAH): Towards a Comprehensive Private Health Insurance Market in China
By: Regina E. Herzlinger and Da Liu
- March 1993
- Case
West Paces Medical Center
By: Regina E. Herzlinger and Sharon Kleefield
Keywords: Health Industry
Herzlinger, Regina E., and Sharon Kleefield. "West Paces Medical Center." Harvard Business School Case 193-139, March 1993.
- September 2012 (Revised August 2015)
- Case
Shanghai Pharmaceuticals
By: Regina E. Herzlinger and Natalie Kindred
Shanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company—essentially a collection of subsidiaries... View Details
Keywords: Business Subsidiaries; Business Conglomerates; Vertical Integration; Decision Choices and Conditions; Mergers and Acquisitions; Consolidation; Health Care and Treatment; Global Strategy; State Ownership; Pharmaceutical Industry; Health Industry; Shanghai; United States; Europe
Herzlinger, Regina E., and Natalie Kindred. "Shanghai Pharmaceuticals." Harvard Business School Case 313-016, September 2012. (Revised August 2015.)
- May 2012 (Revised August 2014)
- Case
McKesson
By: Regina E. Herzlinger and Natalie Kindred
McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010 revenues, just made its first foray into... View Details
Keywords: Health Care Industry; Health Care Policy; Organizational Transformations; Health Services; Health Care and Treatment; Business Model; Service Operations; Change Management; Corporate Strategy; Information Technology; Policy; Pharmaceutical Industry; Health Industry; United States
Herzlinger, Regina E., and Natalie Kindred. "McKesson." Harvard Business School Case 312-002, May 2012. (Revised August 2014.)
- March 2011
- Article
An Angel Investor with an Agenda
By: Regina E. Herzlinger and Beatriz Muñoz-Seca
Keywords: Investment
Herzlinger, Regina E., and Beatriz Muñoz-Seca. "An Angel Investor with an Agenda." Harvard Business Review 89, no. 3 (March 2011).
- January 2010 (Revised August 2012)
- Background Note
Note on Telemedicine
By: Regina E. Herzlinger and Jillian Copeland
This note provides background in all the modalities of telemedicine. It accompanies the cases "Medtronic: Patient Management Initiative" (A) and (B), HBS Nos. 302-005 and 309-064. View Details
Keywords: Interactive Communication; Entrepreneurship; Health Care and Treatment; Technological Innovation; Information Technology; Health Industry; Telecommunications Industry
Herzlinger, Regina E., and Jillian Copeland. "Note on Telemedicine." Harvard Business School Background Note 310-075, January 2010. (Revised August 2012.)
- November 2003 (Revised December 2007)
- Supplement
Circle Gastroenterology Products (B)
By: Regina E. Herzlinger and James Weber
Supplements the (A) case. View Details
Herzlinger, Regina E., and James Weber. "Circle Gastroenterology Products (B)." Harvard Business School Supplement 304-053, November 2003. (Revised December 2007.)
- August 2001 (Revised August 2012)
- Case
BestDoctors, Inc.
By: Regina E. Herzlinger and Seth Bokser
Upon learning the news of a critical illness, patients and their families are shocked, saddened, fearful, and angry all at once. And just as soon as they catch their collective breath, they all ask the same question—a question that has the potential to infuse hope into... View Details
- June 10, 2021
- Article
Preparing Hospitals for the Next Pandemic
By: Regina E. Herzlinger and Barak D. Richman
The COVID-19 epidemic response has shown that the U.S. is blessed with heroic physicians and other health care providers, researchers, and facilities. But it has also revealed a health care system that was woefully unprepared for the surge of pandemic patients. In the... View Details
Keywords: Hospital; Hospital Management; Hospitals—administration; Health Care; Health Care Industry; Health Care Investment; Health Care Operations; Health Pandemics; Health Care and Treatment; Operations; Performance Improvement; Investment; Health Industry; United States
Herzlinger, Regina E., and Barak D. Richman. "Preparing Hospitals for the Next Pandemic." Harvard Business Review Digital Articles (June 10, 2021).
- June 1992
- Teaching Note
Genetics Institute, Inc., Teaching Note
By: Regina E. Herzlinger and James T. Rhea
Keywords: Genetics
- September 2011 (Revised August 2014)
- Background Note
Note on Bundled Payment in Health Care
By: Regina E. Herzlinger and Charles C. Huang
The note explains how bundled health care payment differs from fee-for-service payment, provides examples of the difference between the two, describes early innovators in bundling and their results, provides guidance on how to make it happen, and elucidates the legal... View Details
Herzlinger, Regina E., and Charles C. Huang. "Note on Bundled Payment in Health Care." Harvard Business School Background Note 312-032, September 2011. (Revised August 2014.)